 |
|
Use of Sildenafil Is Safe in Men With Congestive Heart Failure
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Webster et al1 found that the PDE5 inhibitor sildenafil citrate can be safely used in the treatment of ED in men with NYHA classes II and III heart failure. The study by Webster and colleagues1 may include additional data of further clinical importance. It is generally recognized that the concomitant use of nitrates and PDE5 inhibitors is strictly contraindicated. Caution in using PDE5 inhibitors in patients receiving treatment with  -blockers has also been warranted, and combination therapy cannot be recommended. In the product summary of the most recent commercial available PDE5 inhibitor vardenafil hydrochloride (launched in 2003), it is emphasized that clinical data addressing the safety of combination therapy with vardenafil and -blockers are insufficient. Similar conclusions can most likely be drawn for therapy with sildenafil or tadalafil.
Cardiologists and other physicians treating patients with CHF therefore have to anticipate 1 more challenge. The prevalence of ED in these patients . . . [Full Text of this Article]
Hans Mickley, MD, PhD;
Tina Svenstrup Poulsen, MD
Correspondence: Dr Mickley, Department of Cardiology, Odense University Hospital, 5000 Odense C, Denmark (hans.mickley@dadlnet.dk).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Use of Sildenafil for Safe Improvement of Erectile Function and Quality of Life in Men With New York Heart Association Classes II and III Congestive Heart Failure: A Prospective, Placebo-Controlled, Double-blind Crossover Trial
Linda J. Webster, Evangelos D. Michelakis, Terry Davis, and Stephen L. Archer
Arch Intern Med. 2004;164(5):514-520.
ABSTRACT
| FULL TEXT
|
